Novartis Says Accord Can't Make, Sell Generic Bone Drug
Novartis Pharmaceuticals Corp. hit Accord Healthcare Inc. with a patent infringement lawsuit in New Jersey federal court on Tuesday, saying Accord asked the U.S. Food and Drug Administration to approve generic...To view the full article, register now.
Already a subscriber? Click here to view full article